Growing community of inventors

Laurel, MD, United States of America

Patrick Joseph Morris

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Patrick Joseph MorrisCraig J Thomas (6 patents)Patrick Joseph MorrisCarlos A Zarate (3 patents)Patrick Joseph MorrisRuin Moaddel (3 patents)Patrick Joseph MorrisTodd Gould (3 patents)Patrick Joseph MorrisPanos Zanos (3 patents)Patrick Joseph MorrisScott Thompson (2 patents)Patrick Joseph MorrisAdam Van Dyke (2 patents)Patrick Joseph MorrisRichard Andrew Castledine (1 patent)Patrick Joseph MorrisSamuel Lawrence Bourne (1 patent)Patrick Joseph MorrisPatrick Joseph Morris (6 patents)Craig J ThomasCraig J Thomas (24 patents)Carlos A ZarateCarlos A Zarate (8 patents)Ruin MoaddelRuin Moaddel (7 patents)Todd GouldTodd Gould (4 patents)Panos ZanosPanos Zanos (3 patents)Scott ThompsonScott Thompson (3 patents)Adam Van DykeAdam Van Dyke (3 patents)Richard Andrew CastledineRichard Andrew Castledine (1 patent)Samuel Lawrence BourneSamuel Lawrence Bourne (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The United States of America, As Represented by the Secretary, Department of Health and Human Services (6 from 3,439 patents)

2. University System of Maryland (3 from 1,927 patents)


6 patents:

1. 12473251 - Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

2. 11897875 - Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

3. 11613514 - Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

4. 11459320 - Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

5. 11186539 - Process for synthesis and purification of (2R,6R)-hydroxynorketamine

6. 10919842 - Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…